First Time Loading...

BRAIN Biotech AG
XETRA:BNN

Watchlist Manager
BRAIN Biotech AG Logo
BRAIN Biotech AG
XETRA:BNN
Watchlist
Price: 2.78 EUR -1.07% Market Closed
Updated: Apr 24, 2024

BRAIN Biotech AG
Revenue

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

BRAIN Biotech AG
Revenue Peer Comparison

Comparables:
WCH
EVK
1COV
ACT
SY1

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
BRAIN Biotech AG
XETRA:BNN
Revenue
€55.2m
CAGR 3-Years
14%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Wacker Chemie AG
XETRA:WCH
Revenue
€6.4B
CAGR 3-Years
11%
CAGR 5-Years
5%
CAGR 10-Years
4%
Evonik Industries AG
XETRA:EVK
Revenue
€15.3B
CAGR 3-Years
8%
CAGR 5-Years
3%
CAGR 10-Years
2%
Covestro AG
XETRA:1COV
Revenue
€14.4B
CAGR 3-Years
10%
CAGR 5-Years
0%
CAGR 10-Years
N/A
AlzChem Group AG
XETRA:ACT
Revenue
€540.6m
CAGR 3-Years
13%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Symrise AG
XETRA:SY1
Revenue
€4.7B
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
11%

See Also

What is BRAIN Biotech AG's Revenue?
Revenue
55.2m EUR

Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Revenue amounts to 55.2m EUR.

What is BRAIN Biotech AG's Revenue growth rate?
Revenue CAGR 5Y
6%

Over the last year, the Revenue growth was 3%. The average annual Revenue growth rates for BRAIN Biotech AG have been 14% over the past three years , 6% over the past five years .